activistletters
Aadi Bioscience (AADI): BML Investment Partners Blasts Board Over PIPE Dilution and Rejected $5+ Takeout Offer
Summary
BML Investment Partners (owns 9.9% of Aadi) criticized Aadi Biosciences' board for rejecting a full-company sale that
activistletters
Matthews International (MATW): Barington Capital Slams Board Entrenchment and Capital Mismanagement in Proxy Fight
Summary
Barington Capital is leading a proxy fight against Matthews International, criticizing 18 years of value destruction under CEO Joseph
activistletters
Soho House & Co Inc. (SHCO): Third Point Opposes “Sweetheart Deal,” Urges Fair Sale Process Beyond Ron Burkle’s Control
Summary
Third Point, owning 9.9% of Soho House’s Class A shares, criticizes the board for approving a private
activistletters
DMC Global (BOOM): Steel Connect Reiterates Acquisition Proposal, Slams Board Over Value Destruction and $4.5M CEO Pay
Summary
Steel Connect has reaffirmed its interest in acquiring DMC or its subsidiaries and criticized the DMC board for poor
activistletters
Barnwell Industries (BRN): Sherwood Group Condemns Poison Pill, Blasts Board Entrenchment and Excessive Pay
Summary
Ned L. Sherwood, a 30% shareholder of Barnwell Industries, criticizes the company's newly adopted shareholder rights plan
activistletters
Matthews International (MATW): Barington Capital Demands Board Refresh, CEO Change, and Stronger Governance After 18 Years of Value Destruction
Summary
Barington Capital Group is urging shareholders of Matthews International Corp to support its three board nominees at the 2025
activistletters
Ned L. Sherwood vs. Barnwell (BRN): Activist Prepares Five-Director Slate, Attacks Governance, Poison-Pill Tactics, and Legal Spend
Summary
A major shareholder of Barnwell Industries (owning 30%) criticizes the Kinzler and Grossman families for over a decade of
activistletters
Matthews International (MATW): Barington Capital Urges Election of Amicarella, Galbato, Mitarotonda to Replace Entrenched Board After 18 Years of Value Erosion
Summary
Barington Capital is urging Matthews International shareholders to vote for its three director nominees—Ana Amicarella, Chan Galbato, and
activistletters
Apartment Investment and Management Co. (AIV): Land & Buildings Calls for Whole Company Sale After $520M Brickell Deal, Sees 30% Upside
Summary
Land & Buildings praised Aimco's CEO Wes Powell and the board for the $520 million Brickell Assemblage
activistletters
TriMas Corporation (TRS): Barington Capital Urges Strategic Alternatives Over New CEO Hire After Years of Shareholder Underperformance
Summary
Barington Capital urges TriMas to stop the CEO search and instead pursue strategic alternatives, including a sale of the
activistletters
Air Products & Chemicals (APD): Mantle Ridge Urges Shareholders to Back Director Slate, Citing Integrity Crisis, Poor Returns, and Risky Projects
Summary
Mantle Ridge criticized Air Products’ leadership under Seifi Ghasemi, accusing the company of omitting key facts, misleading shareholders about
activistletters
Intrepid Potash (IPI): Gate City Capital Pushes for Capital Returns, Cost Cuts, and Governance Reforms After Leadership Changes
Summary
Gate City Capital (6.37% owner) urged Intrepid Potash to adopt shareholder-friendly policies, including returning 75% of free cash
activistletters
Vera Bradley (VRA): Fund 1 Investments Urges Strategic Alternatives, Citing Value Destruction and Public Market Challenges
Summary
Fund 1 Investments, Vera Bradley’s largest shareholder, urged the company to explore strategic alternatives, including a sale or
activistletters
FIGS Inc. (FIGS): Baron Capital (18% Holder) Opposes Take-Private Proposal, Urges Company to Stay Public
Summary
Baron Capital (18% owner, FIGS’ largest shareholder) opposes the December 2024 take-private proposal, arguing FIGS has a strong balance
activistletters
BML’s Braden Leonard Opposes Aadi Biosciences (AADI) PIPE Financing, Urges Sale or Cash Return to Shareholders
Summary
BML Investment Partners (9.9% owner) strongly opposes Aadi Bioscience’s December 19, 2024 PIPE-financed “AADI 2.0” plan,
activistletters
Fund 1 Investments Proposes Acquisition of Destination XL (DXLG), Citing Retail Strength and Liquidity Challenges
Summary
Fund 1 Investments submitted a non-binding proposal to acquire all outstanding shares of Destination XL Group (DXLG) it does
activistletters
Goodwood Inc. Targets COSCIENS Biopharma (CSCI) Over Cash Burn, Weak Strategy, and Board Accountability
Summary
Goodwood, owning 8.2% of COSCIENS, criticizes the board for burning $11.6M cash in nine months while generating
activistletters
Goodwood Inc. Sent A Letter To Cosciens Biopharma Inc.
Letter Dated December 19, 2024 From Goodwood, Inc. To Cosciens Biopharma Inc.
GOODWOOD INC.
132 Trafalgar Road
Oakville, Ontario
L6J
